QGEN

#958
QIAGEN N.V.
41.89 USD
-0.10%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
41.84
42.00
Jahresspanne
38.80
57.82
Tagesänderung
-0.10%
Monatliche Änderung
+1.75%
6 month change
-11.72%
Jahresänderung
-0.59%
Vorheriger Schlusskurs
41.93
Eröffnung
42.00
Bid
Ask
Tief
41.84
High
42.00
Volumen
347
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 9.09 B
  • Employee 5 654
  • Founded 1984
  • CEO Thierry Bernard
  • Website www.qiagen.com
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
23.18
Preis-Umsatz-Verhältnis
4.79
Dividende je Aktie
0.25
Dividendenrendite in %
0.56

Qiagen N.V

QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer.

Nachrichten